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OBJECTIVE — To investigate the incidence, prevalence, and clinical characteristics of dia-
betes among U.S. non-Hispanic white (NHW) youth.
RESEARCH DESIGN AND METHODS — Data from the SEARCH for Diabetes in
Youth Study (SEARCH study), a multicenter study of diabetes among youth aged 0–19 years,
were examined. Incidence rates were calculated per 100,000 person-years across 4 incident years
(2002–2005), and prevalence in 2001 was calculated per 1,000 youths. Information obtained by
questionnaire, physical examination, and blood and urine collection was analyzed to describe
the characteristics of youth who completed an in-person visit.
RESULTS — The prevalence of type 1 diabetes (at ages 0–19 years) was 2.00/1,000, which
was similar for male (2.02/1,000) and female (1.97/1,000) subjects. The incidence of type 1
diabetes was 23.6/100,000, slightly higher for male compared with female subjects (24.5 vs. 22.7
per 100,000, respectively, P  0.04). Incidence rates of type 1 diabetes among youth aged 0–14
years in the SEARCH study are higher than all previously reported U.S. studies and many
European studies. Few cases of type 2 diabetes in youth aged 10 years were found. The
prevalence of type 2 diabetes (at ages 10–19 years) was 0.18/1,000, which is significantly higher
for female compared with male subjects (0.22 vs. 0.15 per 1,000, P  0.01). Incidence of type
2 diabetes was 3.7/100,000, with similar rates for female and male subjects (3.9 vs. 3.4 per 1,000,
respectively, P  0.3). High levels of abnormal cardiometabolic and behavioral risk factor
profiles were common among youth with both type 1 and type 2 diabetes. For example, within
each of four age-groups for youth with type 1 diabetes and two age-groups for youth with type
2 diabetes, 40% had elevated LDL cholesterol, and 3% of youth aged 10 years met current
recommendations for intake of saturated fat. Among youth aged 15 years, 18% with type 1 and
26% with type 2 diabetes were current smokers.
CONCLUSIONS — The SEARCH study is one of the most comprehensive studies of diabetes
in NHW youth. The incidence of type 1 diabetes in NHW youth in the U.S. is one of the highest
in the world. While type 2 diabetes is still relatively rare, rates are several-fold higher than those
reported by European countries. We believe
efforts directed at improving the cardiometa-
bolic and behavioral risk factor profiles in this
population are warranted.
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A pproximately 20 million people inthe U.S. have been diagnosed withdiabetes (1), a figure driven primar-
ily by type 2 diabetes in adults. In youth,
the burden of diabetes is primarily due to
type 1 diabetes; however, there is increas-
ing concern regarding the diagnosis of
type 2 diabetes at younger ages. The latest
estimates indicate that for type 1 and type
2 diabetes combined, 150,000 youth in
the U.S. had diabetes in 2001 (2), and
18,000 youth were diagnosed annually
with diabetes in 2002–2003 (3).
International studies indicate that
type 1 diabetes is most common among
youth of northern European descent
relative to other populations in the
world. In the multinational World
Health Organization Diabetes Mondiale
(DiaMond) study, rates of type 1 diabe-
tes among youth aged 0 –14 years varied
by 350-fold, from 36/100,000 in Sar-
dinia and Finland to 0.1/100,000 in
China and Venezuela (4). In contrast,
type 2 diabetes is more common among
Hispanic, African American, and Amer-
ican Indian youth (5). In the U.S., stud-
ies of diabetes in youth are generally
limited to those conducted in a single
geographic location. Moreover, there
are limited recent population-based
data on the prevalence and incidence of
type 1 diabetes among non-Hispanic
white (NHW) subjects, while reports of
type 2 diabetes among youth focus
largely on data from members of ethnic
minority groups. In general, these stud-
ies lack information regarding the clin-
ical and behavioral characteristics of
these populations, important factors in
understanding this condition.
To address gaps in knowledge regard-
ing diabetes among NHW youth in the
U.S., this study uses data from the
SEARCH for Diabetes in Youth Study
(SEARCH study) to 1) provide the esti-
● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ●
From the 1Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem,
North Carolina; the 2Department of Nutrition, University of North Carolina School of Public Health,
Chapel Hill, North Carolina; the 3Center for Research in Nutrition and Health Disparities and Department
of Epidemiology and Biostatistics, University of South Carolina, Columbia, South Carolina; the 4Depart-
ment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California; the
5National Institute for Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Be-
thesda, Maryland; the 6Department of Pediatrics, University of Washington, Seattle, Washington; the
7Department of Medicine, University of Washington, Seattle, Washington; the 8Pacific Health Research
Institute, Honolulu, Hawaii; the 9Division of Diabetes Translation, Centers for Diseases Control and
Prevention, Atlanta, Georgia; and the 10Department of Preventive Medicine and Biometrics, University of
Colorado Health Sciences Center, Denver, Colorado.
Corresponding author: Ronny A. Bell, rbell@wfubmc.edu.
The contents of this report are solely the responsibility of the authors and do not necessarily represent the
official views of the Centers for Disease Control and Prevention and the National Institute of Diabetes and
Digestive and Kidney Diseases.
DOI: 10.2337/dc09-S202
© 2009 by the American Diabetes Association. Readers may use this article as long as the work is properly
cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.
org/licenses/by-nc-nd/3.0/ for details.
S102 DIABETES CARE, VOLUME 32, SUPPLEMENT 2, MARCH 2009
mates of prevalence and incidence of dia-
betes among NHW youth in the U.S.,
overall and according to age and sex, and
2) describe the demographic, behavioral,
clinical, and socioeconomic characteris-
tics of this population.
RESEARCH DESIGN AND
METHODS — The SEARCH study is a
multicenter observational study that be-
gan conducting population-based ascer-
tainment of cases of nongestational
diabetes in youth aged 20 years begin-
ning in 2001 and continuing through the
present. Youth with diagnosed diabetes
were identified in geographically defined
populations in Ohio (eight urban and
suburban counties encompassing and
surrounding Cincinnati), Washington
(five urban counties encompassing and
surrounding Seattle), South Carolina, and
Colorado (selected counties in 2001, all
counties in subsequent years); among
managed health care plan enrollees in Ha-
waii and southern California; and among
Indian Health Service beneficiaries in four
American Indian populations. Ascer-
tained case subjects were contacted and
asked to complete an initial patient sur-
vey, and subjects completing the initial
patient survey were invited for an in-
person visit, during which anthropomet-
ric and clinical data and samples were
collected. A detailed description of the
SEARCH study methods has been pub-
lished elsewhere (6).
The SEARCH study sought to identify
all existing (prevalent) cases of diabetes in
2001 and all newly diagnosed (incident)
cases in subsequent calendar years. Dia-
betic cases were considered valid if diag-
nosed by a health care provider. Analyses
herein include NHW cases prevalent in
2001 and incident cases for calendar years
2002–2005. Before implementation of
the protocol, the study was reviewed and
approved by the local institutional review
board(s) that had jurisdiction over the lo-
cal study population, and compliance
with Health Insurance Portability and Ac-
countability Act (HIPAA) regulations was
ensured.
Data collection
Youth with diabetes or their parent/
guardian were asked to complete a short
initial survey that collected information
on race and ethnicity as well as diabetes-
related factors. Self-reported race and eth-
nicity were collected using 2000 U.S.
Census questions (7).
Information about dietary intake,
physical activity, smoking and other
health behaviors, and depressive symp-
toms was collected from participants aged
10 years. Dietary intake was assessed by
a food frequency instrument modified for
administration in youth and designed to
capture regionally and culturally specific
foods in the SEARCH study population,
as previously described (8). Physical ac-
tivity questions were derived from the
Youth Risk Behavioral Surveillance Sys-
tem questionnaire (9). Depressive symp-
toms were assessed using the Center for
Epidemiologic Studies–Depression Scale
score, as previously reported (10,11).
For all participants, blood was drawn
at the study visit for measurement of dia-
betes autoantibodies, A1C, fasting glu-
cose, C-peptides, and lipids. A spot urine
was also collected for measurement of uri-
nary albumin. Specific laboratory meth-
ods for these tests have been previously
described (6). The inter- and intra-assay
variation for these measures are as fol-
lows: cholesterol 1.6 and 0.6%, C-
peptides 3.1 and 1.4%, glucose 1.4 and
0.7%, GHb 0.7 and 0.5%, HDL 1.8 and
0.9%, creatinine 4.3 and 0.7%, triglycer-
ides 1.8 and 1.0%, and urine albumin 3.8
and 2.9%, respectively.
For youth aged 3 years, a brief
physical examination included height,
weight, waist circumference, evaluation
for acanthosis nigricans, and measure-
ment of systolic and diastolic blood pres-
sure (6). All data collection procedures
were conducted following standardized
procedures for training and certification
on the study protocol. Training and data
collection certification is repeated annu-
ally, and selected measures are evaluated
for consistency following duplicate mea-
surement quality-control procedures.
Categorization of key variables
Diabetes type was reported by the health
care professional or abstracted from the
medical records as type 1, type 1a, type
1b, type 2, maturity-onset diabetes of the
young, hybrid, or other type. For this
report, we have restricted our analyses to
youth with type 1 diabetes (including
type 1a and type 1b) or type 2 diabetes.
Case subjects with maturity-onset diabe-
tes of the young, hybrid, other types, or
missing type were excluded (2.5% of reg-
istered case subjects).
Race/ethnicity was categorized some-
what differently for the prevalence and in-
cidence estimates using all registered
youth and for the analysis of respondent
characteristics, which was based on the
subset of youth who had a study visit. For
both analyses, all participants who re-
ported “Hispanic” ethnicity were catego-
rized as “Hispanic,” regardless of their
responses to race questions. For the prev-
alence and incidence estimates, partici-
pants with multiple race categories were
race bridged using methods developed by
the National Center for Health Statistics
(12). Participants with missing race and
ethnicity data or who were classified as
“other race” were geocoded (7.6% of reg-
istered case subjects were either geocoded
or race bridged). For analyses of charac-
teristics of youth with diabetes among the
non-Hispanic participants, those who re-
ported more than one race were placed
into a single race category using the plu-
rality approach. Subjects who could not
be classified to one race group using the
plurality approach (0.5% of study visit
case subjects) and those with missing data
(0.02% of study visit case subjects) were




Methods for estimating diabetes preva-
lence in 2001 have been previously re-
ported (2). Briefly, the numerator for the
analysis included all NHW case subjects
with nongestational diabetes prevalent in
2001 who were aged 20 years on 31
December 2001 and a resident of the de-
fined population in 2001 (geographically
based centers) or a member of the partic-
ipating health plan in 2001 (membership-
based centers). Age was based on the
subject’s age on 31 December 2001. The
study covered 2,025,426 NHW youth
aged 20 years in 2001. The prevalence
of diabetes among NHW youth was ex-
pressed as cases per 1,000 youth using
data pooled across all SEARCH study cen-
ters, with 95% CIs calculated by using an
inverted-score test from the binomial dis-
tribution (13).
Estimation of incidence rates
Annual incidence rates for 2002 and 2003
were published previously (3). Here, we
present more detailed, race/ethnic-
specific incidence rates using diabetic
case subjects ascertained with newly diag-
nosed diabetes over a 4-year period
(2002–2005). Because the 2000 U.S.
Census projections for youth residing in
the participating areas were similar in
2002 and 2003 (0.2% change overall),
for simplicity, the 2002 denominator was
multiplied by four and used as the total
Bell and Associates
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denominator for case subjects ascertained
over the 4-year period of 2002–2005. The
study covered 11,856,800 NHW person-
years at risk. Annual incidence rates were
estimated per 100,000 youth, and 95%
CIs were calculated by using an inverted-




Weight and height were compared with
U.S. standards to calculate normalized z
scores (14). Youth with a BMI z score
95th percentile were considered obese,
85–94.9th percentiles overweight, 5th
percentile to 85th percentile healthy
weight, and 5th percentile underweight
(15). Diabetes therapy was reported as
being on insulin, metformin, both, or
neither. Youth were defined as having di-
abetic ketoacidosis (DKA) at diagnosis
(incident case subjects only) if they had at
least one of the following noted in their
medical record: 1) blood bicarbonate
15 mmol/l or pH 7.25 (venous) or
7.30 (arterial or capillary), 2) ICD-9
code 250.1, or 3) diagnosis of DKA men-
tioned in the medical records (16). Family
history of diabetes was defined as having a
biological sibling, parent, or grandparent
with diabetes. A1C was categorized using
the American Diabetes Association guide-
lines as good (8.0), marginal (8.0–9.4),
and poor (9.5) control (17). Glutamic
acid decarboxlyase (GAD65) levels
0.085 were considered positive (18).
Waist circumference was measured using
the National Health and Nutrition Exam-
ination Survey protocol (19), and high
waist circumference was classified as
90th percentile for age and sex (20).
Hypertension was defined as systolic
and/or diastolic blood pressure 95th
percentile for sex, age, and height (21).
We also examined data on the prevalence
of self-reported hypertension. Abnormal
lipid values were defined as follows, using
previously published treatment guide-
lines (22): triglycerides 110 mg/dl,
HDL cholesterol 40 mg/dl, and LDL
cholesterol 100 mg/dl. High albumin-
to-creatinine ratio (ACR) was defined as
having an ACR of 30 g/mg (23).
Smoking status was classified as
never, former, and current. Participants
were asked the average number of days
they participate in physical activity in a
typical week and were then divided into
two categories: being physically active
0–2 days per week or 3–7 days per week.
Two dietary variables, percent calories
from fat and saturated fat and the average
number of servings of fruits and vegeta-
bles, were obtained by a food frequency
questionnaire as previously described (8).
A score of 24 on the Centers for Epide-
miologic Study Depression Scale (10,11)
was considered to indicate the presence of
depressive symptoms. Annual family in-
come was divided into four categories:
$25,000, $25,000 to $49,999, $50,000
to $74,999, and $75,000. Parental ed-
ucation was classified as less than high
school or at least a high school graduate
and was based on the highest education of
either parent. Insurance was classified for
nonmembership sites as private, Medic-
aid or Medicare, other insurance, or none.
Statistical testing of the demographic,
clinical, behavioral, and socioeconomic
variables was conducted across sub-
groups aged 0–4, 5–9, 10–14, and 15
years for youth with type 1 diabetes and
across the two older age-groups for type 2
diabetes. Comparisons were also made
between youth with type 1 and type 2
diabetes. 2 tests, t tests, or ANOVA were
conducted as appropriate. Mean fasting
C-peptide is reported as adjusted for dia-
betes duration. Percent GAD65 positivity,
high blood pressure, high triglycerides,
low HDL cholesterol, high LDL choles-
terol, apolipoprotein B (apoB), and high
ACR are reported as unadjusted and ad-
justed for duration of diabetes. Linear or
logistic regression was used to adjust for
differences in diabetes duration between
age categories for continuous and dichot-
omous outcomes, respectively. Given the
descriptive and hypothesis-generating
nature of these analyses, we retained use
of the traditional  of 0.05 to determine
statistical significance despite the number
of comparisons made.
RESULTS — A total of 4,243 NHW
youth aged 20 years had diabetes in
2001, and an additional 3,041 youth were
newly diagnosed in 2002–2005. A table
in the online-only appendix (available at
http://care.diabetesjournals.org/cgi/
content/full/dc09-S202/DC1) shows de-
tails of numerators, denominators, and
prevalence and incidence rates with 95%
CIs, according to 5-year age-groups.
There were 4,045 type 1 and 198 type
2 diabetic prevalent case subjects in 2001.
The prevalence of type 1 diabetes for
youth aged 0–19 years was 2.00/1,000,
which was similar for male (2.02/1,000)
and female (1.97/1,000) subjects. The
prevalence of type 2 diabetes among
youth aged 10–19 years was 0.18, which
was significantly higher for female (0.22)
compared with male (0.15, P  0.01)
subjects. A total of 2,800 type 1 incident
case subjects were observed during the
4-year time period. The incidence of type
1 diabetes was 23.6/100,000, with the
rates being slightly higher for male com-
pared with female subjects (24.5/100,000
and 22.7/100,000, respectively, P 
0.04).
A total of 229 patients with type 2
diabetes in the 10–19 year age range were
identified during the 4-year time period,
and only 12 type 2 diabetic patients were
diagnosed when aged 10 years. The in-
cidence of type 2 diabetes for youth aged
10–19 years was 3.7/100,000, with sim-
ilar rates observed for female and male
subjects (3.9/100,000 vs.3.4/100,000, re-
spectively, P  0.3).
Figure 1 presents prevalence esti-
mates (Fig.1A) and annual incidence rates
(Fig. 1B) of type 1 and type 2 diabetes, by
single-year age-groups and sex. The prev-
alence of both type 1 and type 2 diabetes
increased gradually with age. By age 19
years, the prevalence of type 1 diabetes
was 3.33/1,000 for male subjects and
3.69/1,000 for female subjects and the
prevalence of type 2 diabetes was 0.3/
1,000 for both male and female subjects.
Incidence of type 1 diabetes peaked at age
13 years for male subjects (39.07/
100,000) and at age 11 years for female
subjects (40.09/100,000). Rates of type 2
diabetes were highest for male subjects at
age 14 years (6.63/100,000) and at age 15
years for female subjects (6.77/100,000).
Sociodemographic characteristics
For each of the four age-groups, 60% of
youth with type 1 diabetes were from
families with $50,000 annual income
and 78% had private health insurance
(Table 1). In contrast, 45% of youth
with type 2 diabetes were from families
with annual family income of $50,000
and 62% had private health insurance.
Clinical characteristics
Table 1 presents clinical characteristics
according to age within diabetes type. Fo-
cusing first on NHW youth with type 1
diabetes, after adjustment for duration of
diabetes, fasting C-peptide was lowest
among youth aged 0–4 years (0.1 ng/ml),
in whom having DKA at diagnosis was
most common (28.9%). Adjusted preva-
lence of GAD65 positivity was most com-
mon among youth aged 15 years.
Prevalence of having A1C 9.5% was
most common among youth aged 15
Diabetes in non-Hispanic white youth
S104 DIABETES CARE, VOLUME 32, SUPPLEMENT 2, MARCH 2009
years (21.5%) compared with prevalence
that ranged from 3.4 to 11.2% across the
younger age-groups.
About 30% of NHW youth with type
1 diabetes were overweight or obese. After
adjustment for diabetes duration, 5%
had high blood pressure, either by blood
pressure measurement or self-report of a
provider diagnosis, with the exception of
youth aged 0–4 years with prevalence of
12.9%. However, 20% of youth aged
15 years had either high triglyceride
concentration or low HDL cholesterol af-
ter adjustment, and 40% of youth in
each age-group had high LDL cholesterol.
Adjusted prevalence of high ACR ranged
from 5.6% (aged 5–9 years) to 10.4%
(aged 15 years). Prevalence of high
apoB was highest in the youngest and old-
est age-groups.
For NHW youth with type 2 diabetes,
clinical characteristics specific to diabetes
did not differ significantly between
younger (aged 10–14 years) and older
youth (aged 15 years). However, as ex-
pected, fasting C-peptide was substan-
tially higher (3.0 ng/ml) and prevalence
of GAD positivity was substantially lower
(25%) among youth with type 2 com-
pared with type 1 diabetes. Also as ex-
pected, the prevalence of DKA at onset
was significantly lower among youth with
type 2 diabetes (10%), for whom family
history of diabetes was more common
and for whom use of insulin was less com-
mon, compared with youth with type 1
diabetes (P  0.001 for all). Forty-five
percent of youth with type 2 diabetes
used insulin, either alone (21.3%) or in
combination with metformin (24.1%).
There was a significant association be-
tween glycemic control and diabetes type,
with a higher proportion of youth with
type 2 diabetes having good glycemic
control (76.4%) compared with youth
with type 1 diabetes (52.4%) (P 
0.0001).
NHW youth with type 2 diabetes had
substantially higher prevalence of being
overweight or obese compared with
youth with type 1 diabetes (P  0.0001).
Moreover, the prevalence of having high
blood pressure, high triglycerides, and
low HDL cholesterol was higher among
youth with type 2 diabetes compared with
youth with type 1 diabetes (P  0.0001
for all). Median apoB values were signifi-
cantly higher for type 2 compared with
type 1 diabetic youth. Over 40% of youth
with type 2 diabetes had high LDL cho-
lesterol, which was similar to the preva-
lence of high LDL cholesterol among
youth with type 1 diabetes. The preva-
lence of high ACR was also higher among
youth with type 2 compared with those
with type 1 diabetes.
Behavioral characteristics
Behavioral characteristics can be found in
Table 2. Current smoking was more com-
mon among NHW youth with type 2
compared with youth with type 1 diabetes
(19.8 vs. 8.8%, P 0.0001). Participation
in moderate- or vigorous-intensity physi-
cal activity 3 days/week was reported by
at least 49% of each age- and diabetes-
type group but was less common among
youth with type 2 compared with type 1
diabetes (P  0.03). Across all age- and
diabetes-type groups, percent of energy
from saturated fat was nearly twice the
recommendation of 7% (24).
CONCLUSIONS — With a popula-
tion of 2 million youth under surveil-
lance for prevalence and 20 million
person-years for which diabetes inci-
dence is estimated, the SEARCH study
Figure 1—Incidence (A) and prevalence (B) of diabetes among NHW youth according to age, sex,
and diabetes type. , type 1 diabetic male subjects; f, type 1 diabetic female subjects; Œ, type 2
diabetic male subjects; 	, type 2 diabetic female subjects.
Bell and Associates
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Table 1—Sociodemographic and clinical characteristics of youth with type 1 or type 2 diabetes: the SEARCH study prevalent 2001 and incident
2002–2005 cases
Type 1 diabetes Type 2 diabetes
P‡0–4 5–9 10–14 15 P* 10–14 15 P†
Sociodemographic characteristics
Income 0.0036 0.9565 0.0001
$25,000 27 (9.8) 80 (9.9) 116 (9.6) 73 (8.6) 11 (29.7) 20 (31.7)
$25,000–$49,000 78 (28.4) 183 (22.6) 223 (18.5) 168 (19.8) 9 (24.3) 17 (27)
$50,000–$74,000 71 (25.8) 169 (20.9) 287 (23.8) 190 (22.4) 10 (27) 14 (22.2)
$75,000 99 (36) 376 (46.5) 580 (48.1) 417 (49.2) 7 (18.9) 12 (19)
Education 0.0190 0.7478 0.0003
Less than high school 1 (0.3) 12 (1.4) 31 (2.5) 11 (1.2) 3 (7.1) 4 (5.6)
High school graduate or higher 295 (99.7) 832 (98.6) 1231 (97.5) 940 (98.8) 39 (92.9) 67 (94.4)
Insurance§ 0.0001 0.0466 0.0001
Private 220 (78.6) 637 (81.5) 981 (84.6) 744 (87) 30 (78.9) 33 (52.4)
Medicaid/Medicare 54 (19.3) 127 (16.2) 150 (12.9) 78 (9.1) 8 (21.1) 26 (41.3)
Other 3 (1.1) 13 (1.7) 13 (1.1) 15 (1.8) 2 (3.2)
None 3 (1.1) 5 (0.6) 15 (1.3) 18 (2.1) 2 (3.2)
Clinical characteristics




 0.04 0.3 
 0.02 0.5 
 0.02 0.6 
 0.02 0.0001 3.4 
 0.4 3.7 
 0.3 0.5892 0.0001
GAD antibody positive 115 (55) 371 (51.5) 618 (54.4) 451 (51) 0.3690 6 (15) 15 (23.4) 0.2970 0.0001
Duration adjusted (%) 46.4 46.3 52.9 59 0.0001 14.8 23.6 0.2981 0.0001
DKA at onset n (% yes) 73 (28.9) 94 (18.5) 143 (24) 37 (15.8) 0.0007 3 (8.8) 1 (2.6) 0.2411 0.0008
Family history of diabetes 0.0001 0.9734 0.0001
Yes¶ 133 (44.8) 404 (47.9) 714 (56.8) 528 (55.1) 32 (78) 56 (77.8)
No 164 (55.2) 439 (52.1) 544 (43.2) 430 (44.9) 9 (22) 16 (22.2)
Diabetes therapy (current) 0.0020 0.7264 0.0001
Insulin 297 (100) 835 (99.4) 1,245 (98.7) 927 (97.1) 10 (25) 13 (19.1)
Metformin 3 (0.2) 2 (0.2) 19 (47.5) 34 (50)
Both 5 (0.6) 12 (1) 23 (2.4) 8 (20) 18 (26.5)
None 1 (0.1) 3 (0.3) 3 (7.5) 3 (4.4)
A1C 0.0001 0.3267 0.0001
 8% 108 (52.7) 433 (59.7) 622 (53.6) 399 (44.7) 29 (70.7) 52 (80)
8–9.5% 90 (43.9) 255 (35.2) 408 (35.2) 302 (33.8) 7 (17.1) 5 (7.7)
9.5% 7 (3.4) 37 (5.1) 130 (11.2) 192 (21.5) 5 (12.2) 8 (12.3)
BMI z score 0.6 
 1 0.6 
 0.9 0.6 
 0.9 0.6 
 0.9 0.9554 1.9 
 0.8 2.1 
 0.6 0.1331 0.0001
Weight 0.4615 0.0773 0.0001
Underweight/normal 127 (70.2) 575 (69.8) 840 (68.2) 641 (69.1) 7 (17.1) 3 (4.7)
Overweight 85th–95th percentile 37 (20.4) 148 (18) 260 (21.1) 194 (20.9) 3 (7.3) 9 (14.1)
Obese 95th percentile 17 (9.4) 101 (12.3) 131 (10.6) 92 (9.9) 31 (75.6) 52 (81.3)
High waist circumference** 36 (20.8) 97 (11.9) 162 (13.4) 125 (14) 0.0214 33 (78.6) 55 (87.3) 0.2342 0.0001
Acanthosis nigricans n (% yes) 3 (1.6) 9 (1.1) 26 (2.1) 18 (2) 0.3499 16 (43.2) 16 (25.8) 0.0727 0.0001
High blood pressure†† 22 (13.1) 41 (5.1) 53 (4.4) 39 (4.2) 0.0001 13 (31.7) 4 (6.2) 0.0005 0.0001
Duration adjusted (%) 12.9 5 4.4 4.3 0.0001 30.6 6.3 0.0033 0.0001
Self-reported hypertension 6 (0.7) 16 (1.3) 62 (6.5) 0.0001 11 (26.8) 22 (31.4) 0.6089 0.0001
Duration adjusted (%) 0.8 1.3 5 0.0001 26.2 31.8 0.5463 0.0001
High triglycerides (110 mg/dl) 3 (1.8) 26 (4) 115 (10.8) 204 (25) 0.0001 21 (56.8) 39 (60.9) 0.6802 0.0001
Duration adjusted (%) 2.1 4.4 11 22.1 0.0001 57.9 60.4 0.8147 0.0001
Low HDL cholesterol (40 mg/dl) 27 (13.4) 45 (6.3) 123 (10.7) 163 (18.3) 0.0001 21 (52.5) 46 (69.7) 0.0751 0.0001
Duration adjusted (%) 11.8 5.8 10.3 20.1 0.0001 46.7 74.1 0.0113 0.0001
High LDL cholesterol (100 mg/dl) 91 (53.8) 291 (45.3) 445 (41.9) 369 (45.2) 0.0275 16 (43.2) 36 (56.3) 0.2076 0.1654
Duration adjusted (%) 57.9 47.8 42.7 41.3 0.0006 44.5 55.5 0.3049 0.0631
ApoB median (interquartile range) 75 (17.5) 71 (22) 71 (23) 76 (26) 0.0001 83 (32) 90 (40) 0.1049 0.0001
Duration adjusted median
(interquartile range)
74.8 (0.7) 68.3 (2.0) 70.1 (3.2) 76.4 (5.3) 0.0001 79.6 (2.3) 89.7 (7.1) 0.2220 0.0001
High ACR (30) 13 (6.9) 40 (5.4) 112 (10.1) 89 (10.8) 0.0006 5 (11.9) 9 (15.3) 0.6311 0.0872
Duration adjusted (%) 7.1 5.6 10.2 10.4 0.0036 13.3 12.7 0.9342 0.0498
Data are n (%), unless otherwise indicated. Physical examination data not collected on youth aged 3 years. *For categorical variables using 2 test for the association
between variable levels and age-groups within type 1 diabetes; for continuous variables using ANOVA for the overall effect of age-group within type 1 diabetes; for
adjusted variables using logistic regression (categorical variables) or linear regression (continuous variables) for the overall effect of age-group within type 1 diabetes.
†For categorical variables using 2 test for the association between variable levels and age-groups within type 2 diabetes; for continuous variables using ANOVA for
the overall effect of age-group within type 2 diabetes; for adjusted variables using logistic regression (categorical variables) or linear regression (continuous variables)
for the overall effect of age-group within type 2 diabetes. ‡For categorical variables using 2 test for the association between variable levels and diabetes type (type
1 versus type 2); for continuous variables using ANOVA for the overall effect of diabetes type (type 1 versus type 2); for adjusted variables using logistic regression
(categorical variables) or linear regression (continuous variables) for the overall effect of diabetes type (type 1 versus type 2). §Only nonmembership sites (South
Carolina, Ohio, Washington, and Colorado). Incident cases only. ¶Family history includes parents, grandparents, and biological siblings. **Waist circumference
90th percentile for age and sex. ††Measured blood pressure (systolic or diastolic)  age-, sex-, and height-specific 95th percentile.
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represents the largest standardized regis-
try of diabetes in NHW youth in the U.S.
We found an overall prevalence of
type 1 diabetes of 2.0/1,000 in NHW
youth aged 20 years. In general, the
prevalence of type 1 diabetes in children
aged 15 years ranges from 0.5/1,000 to
3/1,000 in most European and North
American populations (25). Comparisons
of prevalence estimates across popula-
tions may be subject to bias, since preva-
lence is determined not only by disease
incidence but also by migration and sur-
vival, which may vary markedly by coun-
try or region. Prevalence data, however,
are useful in determining the public
health impact of a specific condition.
Based on the SEARCH study data, we es-
timated that in 2001, the number of type
1 diabetic NHW youth aged 20 years in
the U.S. was 100,300 (2).
To facilitate comparison with pub-
lished data from prior registries in Europe
and the U.S., we also estimated the age-
standardized annual incidence of type 1
diabetes in NHW SEARCH study youth
aged 0 –14 years (Table 3). The age-
standardized annual incidence of type 1
diabetes among NHW SEARCH study
youth aged 0 –14 years was 27.5/
100,000. European studies, which typi-
cally show the highest rates of type 1
diabetes of any population in the world,
also show large rate variations across geo-
graphic areas. Rates of type 1 diabetes re-
ported by the DiaMond study throughout
the 1990s among youths aged 0–14 years
in European countries ranged from 5.3/
100,000 in Bucharest, Romania, and 7.6/
100,00 in Cracow, Poland, to 20/100,000
in Norway, and 40/100,000 in Finland
(4,26) (Table 3). Therefore, the incidence
of type 1 diabetes among NHW children
aged 0–14 years reported by the SEARCH
study is one of the highest in the world.
Table 3—Age-standardized incidence of type 1 diabetes in Caucasian children aged
<14 years (per 100,000/year) from selected studies







subjects Total (95% CI)
Selected European countries*
Finland 1990–1999 41.9 39.9 40.9 (39.6–42.2)
Italy (Sardinia) 1990–1998 45.0 30.6 37.8 (35.5–40.3
Sweden 1990–1999 30.5 29.4 30.0 (29.1–30.8)
Norway (eight counties) 1990–1999 21.6 19.9 20.8 (19.4–22.1)
U.K. (Plymouth) 1990–1999 17.1 20.8 19.0 (16.8–21.2)
Germany (Baden-Württemberg) 1990–1998 12.7 12.6 12.6 (12.1–13.2)
Slovakia 1990–1999 9.7 9.7 9.7 (9.2–10.3)
Italy (Lazio) 1990–1999 8.9 8.6 8.8 (8.1–9.4)
Lithuania 1990–1999 7.6 8.2 7.9 (7.3–8.5
Poland (Cracow) 1990–1999 7.5 7.6 7.6 (7.0–8.2)
Romania (Bucharest) 1990–1999 4.7 5.9 5.3 (4.7–6.1)
Selected U.S. studies in Caucasian
populations
U.S. (SEARCH) 2002–2005 27.9 27.0 27.5 (26.4, 28.6)
U.S. (Allegheny)* 1990–1994 19.1 16.4 17.8 (15.45–20.33)
U.S. (Philadelphia)† 1995–1999 13.0 (10.2–15.6)
U.S. (Chicago)* 1995–1999 19.0 17.5 18.3 (15.7–22.2)
U.S. (Alabama)* 1990–1995 14.1 15.1 14.6 (12.2–18.2)
U.S. (Colorado)‡ 1978–1988 17.5 15.5 16.4 (15.0–17.8)
*Based on ref. 26. ‡Based on ref. 30. ‡Based on ref. 27.
Table 2—Behavioral characteristics of youth with type 1 or type 2 diabetes: the SEARCH study prevalent 2001 and incident 2002–2005 case
subjects aged >10 years
Type 1 diabetes Type 2 diabetes
P‡10–14 15 P* 10–14 15 P†
Smoking 0.0001 0.0079 0.0001
Never 1,143 (93.5) 531 (57.2) 32 (78) 31 (47.7)
Former 60 (4.9) 227 (24.5) 5 (12.2) 17 (26.2)
Current 19 (1.6) 170 (18.3) 4 (9.8) 17 (26.2)
Physically active 0.0003 0.6570 0.0300
0–2 days/week 431 (35.2) 398 (42.8) 19 (46.3) 33 (50.8)
3–7 days/week 792 (64.8) 531 (57.2) 22 (53.7) 32 (49.2)
% Kcal from fat
Total fat 37.8 
 5.9 38.3 
 5.9 0.0433 39.1 
 7.5 39.8 
 5.4 0.6169 0.0194
Saturated fat 13.7 
 2.3 13.8 
 2.4 0.3309 13.8 
 2.6 14.5 
 2.2 0.2219 0.0809
Fruits, vegetables servings/day 2.7 
 1.8 3.1 
 2.1 0.0001 3.2 
 3 2.5 
 1.6 0.1665 0.7192
High CES-D score (24) 65 (5.3) 66 (7.1) 0.0852 9 (22) 11 (17.5) 0.5701 0.0001
Data are n (%) or means 
 SD. *For categorical variables using 2 test for the association between variable levels and age-groups within type 1 diabetes; for continuous
variables using ANOVA for the overall effect of age-group within type 1 diabetes; for adjusted variables using logistic regression (categorical variables) or linear
regression (continuous variables) for the overall effect of age-group within type 1 diabetes. †For categorical variables using 2 test for the association between variable
levels and age-groups within type 2 diabetes; for continuous variables using ANOVA for the overall effect of age-group within type 2 diabetes; for adjusted variables
using logistic regression (categorical variables) or linear regression (continuous variables) for the overall effect of age-group within type 2 diabetes. ‡For categorical
variables using 2 test for the association between variable levels and diabetes type (type 1 versus type 2); for continuous variables using ANOVA for the overall effect
of diabetes type (type 1 versus type 2); for adjusted variables using logistic regression (categorical variables) or linear regression (continuous variables) for the overall
effect of diabetes type (type 1 versus type 2). CES-D, Centers for Epidemiologic Study Depression Scale.
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Additionally, SEARCH study type 1 dia-
betes incidence rates for youth aged 15
years were 68% higher than those re-
ported in the 1980s in Colorado (27); 88
and 54% higher than those reported in
the early 1990s in Alabama and Allegheny
county, respectively (28,29); and 111 and
50% higher than noted in the late 1990s
in Philadelphia (30) and Chicago, respec-
tively (31). These data suggest that the
incidence of type 1 diabetes in NHW
youth may be increasing in the U.S.,
which would be consistent with world-
wide trends (32).
There is a paucity of data on type 2
diabetes among NHW youth. In the
SEARCH study, type 2 diabetes was ex-
ceptionally rare among NHW youth aged
10 years. Even among youth aged
10–19 years, the annual incidence rate
was only 3.7/100,000. Similarly, data
from the Chicago registry indicated rates
of non–type 1 diabetes among youth aged
0–17 years of 2.8/100,000 in 2003 (31).
However, recent studies (33,34) from Eu-
rope show prevalence and incidence esti-
mates much lower than those reported in
the present study, indicating that type 2
diabetes remains a rarity in these popula-
tions. For example, studies from Ger-
many, Austria, France, and the U.K. (35–
37) all show type 2 diabetes accounting
for only 1–2% of all pediatric diabetes
cases. Using an Austrian national register,
Rami et al. (38) found that type 2 diabetes
represented only 1.5% of all newly diag-
nosed cases of diabetes in those aged 15
years from 1999–2001, giving an inci-
dence of 0.025/100,000 per year. A single
center in France (36) reported that only
2% of 382 children (aged 1–16 years)
with diabetes had type 2 diabetes. In con-
trast, in the SEARCH study, type 2 diabe-
tes accounted for almost 15% of all
diabetes cases among NHW adolescents
aged 10 years (3). A survey of all chil-
dren (aged 0 –16 years) with diabetes
from 177 British pediatric diabetes cen-
ters found a prevalence of type 2 diabetes
of 0.002/1,000 (39). In contrast,
SEARCH study data show a prevalence of
diagnosed type 2 diabetes among those
aged 10 –19 years that is 100-fold
higher than the British estimates (0.18/
1,000). Differences in physical activity
levels or food choices and subsequent
obesity rates between populations may
partly explain the lower type 2 diabetes
prevalence and incidence in European
studies compared with SEARCH study
data; however, the full explanation for
these discrepancies remains unclear.
The age distribution of incidence
rates of type 1 diabetes in this population
is consistent with very recent data from
Finland (40) and different from that
noted among Colorado non-Hispanic
youth in the1980s (25), suggesting that
age at onset of type 1 diabetes has been
decreasing over time. Interestingly, the
incidence rates of type 1 diabetes seem to
peak at an earlier age for female compared
with male subjects, again consistent with
recent data from Finland, the country
with the highest incidence of type 1 dia-
betes in the world (40). Consistent with
numerous previous studies (41–43), the
peak age at onset of type 2 diabetes in our
population is around puberty (aged
14–15 years), a period thought to coin-
cide with a physiological rise in insulin
resistance.
There was a fairly consistent pattern
of incidence of diabetes for NHW youth
compared with other racial and ethnic
groups in the SEARCH study (3). For all
age-groups, incidence rates of type 1 dia-
betes were highest for NHW youth com-
pared with the other racial and ethnic
groups (African American, Hispanic,
Asian/Pacific Islander, and Navajo; online
appendix tables). Conversely, rates for
type 2 diabetes were consistently lowest
across age-groups for NHW youth com-
pared with the other four groups. Inci-
dence rates for type 2 diabetes among
African American youth were more than
fourfold higher and among Navajo youth
about sevenfold higher compared with
NHW youth. Further investigation is
needed to more fully understand these
patterns.
The SEARCH study conducted a
comprehensive examination of sociode-
mographic, clinical, and behavioral char-
acteristics of youth with diabetes. In adult
populations, type 2 diabetes has been as-
sociated with lower socioeconomic status
(44), consistent with markers of lower so-
cioeconomic status observed in the
present study among youth with type 2
compared with type 1 diabetes. Also con-
sistent with this finding, Eppens et al.
(45) reported a comparison of 1,433 Aus-
tralian adolescents with type 1 diabetes
and 68 similarly aged youth with type 2
diabetes and found worse social disad-
vantage score among those with type 2
diabetes (P  0.058).
Scott et al. (42) compared clinical
characteristics between youth with type 1
and type 2 diabetes at the time of diagno-
sis and found similar A1C but substan-
tially higher C-peptide level and higher
prevalence of obesity among those with
type 2 diabetes. From the work of Eppens
et al. (45), with average diabetes duration
of 6.8 years for youth with type 1 diabetes
and 1.3 years for those with type 2 diabe-
tes, A1C was significantly lower among
those with type 2 compared with those
with type 1 diabetes, similar to the
present results.
A significant excess prevalence of
components of the metabolic syndrome,
and of the metabolic syndrome itself us-
ing the age-modified definition of the Na-
tional Cholesterol Education Program
Adult Treatment Panel III criteria, was
previously reported by the SEARCH
study for youth with type 2 compared
with those with type 1 diabetes (46). That
study showed that NHW youth had the
lowest prevalence of metabolic syndrome
compared with the racial and ethnic
groups represented in the SEARCH study.
This study also showed that NHW youth
had the lowest prevelance of high blood
pressure, low HDL cholesterol, and high
waist circumference.
Eppens et al. (45) similarly reported
higher prevalence of hypertension, obe-
sity, and microalbuminuria among youth
with type 2 compared with those with
type 1 diabetes. Wadwa (47) recently re-
viewed cardiovascular disease (CVD) risk
in youth with diabetes, with an emphasis
on type 1 diabetes because of its greater
prevalence among youth compared with
type 2 diabetes. As noted by Wadwa (47),
it is important to emphasize the high
prevalence of CVD risk factors in youth
with type 2 diabetes and, at the same time,
to take note that by age 55 years an esti-
mated 35% of individuals with type 1 di-
abetes die of coronary artery disease
compared with 8% of nondiabetic men
and 4% of nondiabetic women.
In the present study, among youth
with type 1 diabetes aged 15 years,
20% had high triglyceride or low HDL
cholesterol concentrations, and 40%
had LDL cholesterol 100 mg/dl after ad-
justing for diabetes duration. Schwab et
al. (48) reported analyses from records
from a large cohort of youth with type 1
diabetes registered across 195 medical
centers and found prevalence of CVD risk
factors including dyslipidemia, hyperten-
sion, BMI z score, and smoking to be
more common among older (aged 17–26
years) compared with younger subjects
(aged 17 years). The prevalence of dys-
lipidemia was 34% among older individ-
uals, and elevated systolic blood pressure
was 11%. Unique in this analysis is the
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reporting of levels of apoB in youth with
type 1 and type 2 diabetes, which was
particularly high among older youth with
type 2 diabetes. A recent consensus report
from the American Diabetes Association
and the American College of Cardiology
(49) suggests treatment guidelines for
apoB of 90 mg/dl (the median for older
youth with type 2 in the SEARCH study)
for high-risk diabetic patients (no other
CVD risk factors) and 80 mg/dl for
highest-risk patients (one or more addi-
tional CVD risk factors). In a previous
SEARCH study report, Albers et al. (50)
reported high rates of elevated apoB and
dense LDL cholesterol among youth with
type 2 diabetes, particularly those with
poor glycemic control. Further research is
needed to more fully understand these
CVD risk factors in youth with diabetes.
In multivariate analyses, overweight
was most closely associated with number
of CVD risk factors, followed by age.
About 30% of youth with type 1 diabetes
in the SEARCH study were overweight or
obese, and lifestyle behaviors potentially
conducive to difficulties in weight man-
agement including high prevalence of
physical inactivity and low intake of fruits
and vegetables were common. Thus, fu-
ture studies should focus on the problem
of overweight and obesity among youth
not only with type 2 diabetes but also
among youth with type 1 diabetes, with
consideration of both the metabolic im-
pact of overweight and obesity for youth
with diabetes and healthy approaches to
weight management.
This report has some limitations that
must be considered. First, analyses derive
from the initial research visit only and thus
are cross-sectional, so we are unable to ex-
amine factors such as the clinical course of
diabetes in these participants. Prospective
data collection is underway. Furthermore, a
substantial proportion of youth did not par-
ticipate in the research visit. Across all ra-
cial/ethnic groups in the SEARCH study,
participation in this visit was lower for older
youth, youth with type 2 versus type 1 dia-
betes, and among African Americans (51).
For this analysis, 52% of all registered
NHW patients had a research visit. How-
ever, we did show previously that using a
weighted estimate based on age, sex, race/
ethnicity, diabetes type, and diabetes dura-
tion distribution for all registered case
subjects did not substantially change our
findings in estimating the prevalence of el-
evated albumin (52).
Nonetheless, the SEARCH study is
one of the largest, most comprehensive
studies of diabetes in NHW youth. This
analysis provided a unique opportunity to
examine the burden of diabetes among
NHW youth in the U.S. According to the
SEARCH study, the incidence of type 1
diabetes in NHW youth in the U.S. is now
one of the highest in the world, with rates
similar to those reported by northern Eu-
ropean countries. Type 2 diabetes is still a
relatively rare condition among NHW
U.S. adolescents, but rates are several-fold
higher than those reported by several Eu-
ropean countries. Further research from
the SEARCH study will allow for the esti-
mation of trends in incidence of diabetes
among NHW youth, according to diabe-
tes type and sex. Additionally, efforts di-
rected at improving the cardiometabolic
and behavioral risk factor profile in this
population are warranted.
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